Interconnected Biatrial Myxoma Spanning the Fossa Ovalis Authors: Jonathan Cayo Urdiales Herrera, Heleutério da Conceição Nicolau Madogolele, Rafael Ruas Nastari, Ricardo Ribeiro Dias, Max Walter Reyes Barrenechea, Fabio Fernandes, Viviane Tiemi Hotta Published: 2026 ABSTRACT AbstractBackgroundBiatrial myxomas are exceptionally rare; an even more unusual variant is a single tumor that straddles the interatrial septum through the fossa ovalis, forming 2 synchronous masses.Case SummaryA 74-year-old woman undergoing routine echocardiography displayed mobile lesions (3.1 × 1.4 cm left, 3.6 × 1.7 cm right) arising from a common pedicle traversing the fossa ovalis. Transesophageal echocardiography, cardiac magnetic resonance, and computed tomography confirmed a biatrial myxoma with a continuous stalk crossing the septum. Surgery achieved complete en bloc resection; recovery was uneventful aside from transient sinus bradycardia.DiscussionThis case illustrates the diagnostic value of multimodality imaging in defining a myxoma that bridges the atrium—a configuration predisposing to both systemic and pulmonary embolization—and demonstrates the excellent prognosis with prompt surgical excision.Take-Home MessagesMultimodality imaging guides precise surgical planning. Early complete resection prevents dual-chamber embolic complications.Key words: cardiac myxoma, cardiovascular tumors, multimodality imaging Integrated Overview of Cardiac Myxoma, Including Epidemiology, Anatomical Distribution, Clinical Manifestations, and Outcomes, Emphasizing Embolic Complications and the Role of Surgical Management in Determining Prognosis LVOT = left ventricular outflow tract. Cardiac tumors are uncommon, with primary lesions occurring in only 0.02% of the population; three-fourths of them are benign. Myxomas account for roughly half of all primary cardiac tumors in adults and are typically sporadic (95%), occasionally familial or syndromic. They show a female predominance and arise most often in the left atrium (75%). Less frequent sites include the right atrium (15%), the left and right ventricles (3% each), and both atria simultaneously in about 2.5% of cases, while truly multiple locations are exceptional (1%).1,2 Take-Home Messages •Atrial myxoma is the most common primary cardiac tumor in adults, and once diagnosed, it should be treated with surgical excision to reduce the risk of arterial thromboembolic events. Atrial myxoma is the most common primary cardiac tumor in adults, and once diagnosed, it should be treated with surgical excision to reduce the risk of arterial thromboembolic events. •Current multimodal imaging diagnostic methodology can predict the histological type of the intracavitary mass based on its morphological characteristics, as well as its location and epidemiology. Current multimodal imaging diagnostic methodology can predict the histological type of the intracavitary mass based on its morphological characteristics, as well as its location and epidemiology. Biatrial myxomas are usually separate masses, and their clinical presentation depends on size and chamber involvement, yet many patients remain asymptomatic and the myxomas are discovered incidentally. Multimodality imaging clarifies anatomy and guides surgical planning, and complete resection remains the definitive treatment, preventing embolic events and minimizing recurrence. The present report describes an exceedingly rare incidentally detected biatrial myxoma connected across the fossa ovalis in an asymptomatic elderly woman, emphasizing the diagnostic value of comprehensive cardiovascular imaging and timely surgical management in this setting. History of presentation A 74-year-old woman, entirely asymptomatic, was referred after screening transthoracic echocardiography (TTE) revealed 2 mobile atrial masses. She reported no chest pain, dyspnea, palpitations, syncope, or embolic events. Vital signs were stable, and physical examination was unremarkable. Past medical history The patient had well-controlled systemic hypertension managed with losartan, hydrochlorothiazide, and amlodipine. There was no history of structural heart disease, arrhythmia, malignancy, or thromboembolic events. Differential diagnosis The initial differential for biatrial masses included cardiac thrombus, primary benign tumors (myxoma, papillary fibroelastoma, lipoma), and metastatic cardiac disease. Investigation Initial blood test revealed a white blood cell count of 8,900/mm3 (normal range: 3,500-10,500/mm3), hemoglobin of 13.9 g/dL (normal range: 12-15 g/dL), and platelet count of 365,000/mm3 (normal range: 150,000-450,000/mm3). The electrocardiogram showed first-degree atrioventricular block, without other arrhythmia. TTE demonstrated a 3.1 × 1.4 cm pedunculated left atrial mass and a 3.6 × 1.7 cm right atrial mass, both attached to the interatrial septum at the fossa ovalis, with no obstruction of atrioventricular inflow (Figure 1). Transesophageal echocardiography confirmed prolapse of each mass into the respective ventricle, ill-defined, suggestive of a myxoma (Figure 2, Video 1). Transthoracic Echocardiography of the Biatrial Myxoma TTE images depicting the biatrial myxoma (yellow arrows) on modified parasternal long-axis view (A) and transversal short-axis view of the great vessels (B). TTE images of the myxoma (yellow arrow) in the right atrium (C). Biatrial myxoma on apical 4-chamber view (D) and myxoma (yellow arrow) in the left atrium on apical 2-chamber view (E) and longitudinal view (F). TTE = transthoracic echocardiography. 2-Dimensional and 3-Dimensional Transesophageal Echocardiography of the Biatrial Myxoma 2-dimensional TEE images depicting the myxoma (yellow arrows) in the left atrium on modified 4-chamber view (A), in the right atrium (B and C) and in the left atrium (B and D) on modified bicaval view (C). 3-dimensional TEE image of the myxoma (yellow arrow) in the left atrium on transgastric 4-chamber view (E) and en face view (F). TEE = transesophageal echocardiography. Cardiac magnetic resonance and contrast-enhanced computed tomography were performed for tissue characterization (Figure 3). The T2-weighted image showed a right atrial mass with heterogeneous hypersignal, typical of myxoma, and heterogeneous patchy enhancement in the left atrial mass on late gadolinium enhancement. Coronary computed tomography angiography excluded concomitant coronary disease. Routine laboratory tests were normal. Cardiac Magnetic Resonance Imaging (A) T2-weighted (triple inversion-recovery) image shows a right atrial mass with heterogeneous hypersignal, typical of myxoma. (B) Rest perfusion reveals minimal diffuse perfusion in the right atrial mass and none in the left atrial mass. (C) Late gadolinium enhancement shows heterogeneous patchy enhancement in the left atrial mass and none in the right. (D) T2-weighted (double inversion-recovery fat-saturated) image shows a hypersignal in the right atrial mass without a fat component. LA = left atrium; LV = left ventricle; RA = right atrium; RV = right ventricle. Management Given the embolic risk of a tumor spanning both atria, surgery was performed. Through median sternotomy and cardiopulmonary bypass, the interconnected masses were excised en bloc along with a cuff of septal tissue (Figure 4); the interatrial septum was closed primarily. Histopathology confirmed myxoma (Figure 5). Computed Tomography and Surgical Management Images Contrast-enhanced coronary computed tomography showing masses in the left atrium and right atrium on the 4-chamber longitudinal view (A) and in the left atrium on longitudinal view of the left ventricular outflow tract (B) and 2-chamber longitudinal view (C). Three-dimensional reconstruction of a longitudinal view showing myxoma in the left atrium (D). Exposure of myxoma in the left atrium (arrows) during surgical treatment (E). Macroscopy of resected myxomas during surgery (F). Abbreviations as in Figure 3. Histological Section of the Left Atrial Tumor Characterized by the Presence of Sparse Elongated or Stellate Cells Immersed in a Myxoid Matrix (A and B) Hematoxylin and eosin staining. Histological section of the right atrial tumor characterized by the presence of sparse elongated or stellate cells immersed in a slightly purple myxoid matrix. Discussion Biatrial myxomas, comprising only 2.5% of cases, are often misdiagnosed as unilateral myxomas; when they occur, it is essential to consider genetic syndromes such as multiple endocrine neoplasia, von Hippel-Lindau syndrome, neurofibromatosis type 1, and Carney complex. Familial syndromes tend to show multiple locations in 45% of cases.3,4 Although they are frequently asymptomatic, complications may occur and are primarily determined by mobility, attachment site, and surface characteristics.1,2 Pedunculated tumors may prolapse through atrioventricular valves during diastole, producing a dynamic obstruction often described as a “tumor plop” phenomenon.5 In left atrial tumors, this may mimic mitral stenosis physiology, resulting in exertional dyspnea, syncope, pulmonary congestion, or sudden cardiac death.2 Right-sided involvement may similarly interfere with tricuspid inflow, producing signs of right heart failure or functional tricuspid stenosis.6 Systemic embolization remains the most frequent complication and may occur even in minimally symptomatic patients. The friable and heterogeneous architecture of myxomas predisposes to fragmentation or thrombus formation along the tumor surface.2 Cerebral embolism is most common, though coronary, renal, and peripheral embolic events are well described. Importantly, embolic risk is not strictly proportional to tumor size, reinforcing the rationale for prompt intervention once diagnosis is established.1 Although TTE is typically sufficient for detection, diagnostic suspicion should not rely solely on the identification of a pedicle. Features that support the diagnosis of myxoma include septal origin, marked mobility, heterogeneous echotexture, and dynamic valve interaction.1,5 In biatrial presentations, careful evaluation of septal integrity is essential to distinguish 2 independent masses from a single tumor extending across the interatrial septum. While TTE is the primary tool, transesophageal echocardiography refines the assessment of stalk insertion and chamber involvement. In complex cases, cardiac magnetic resonance enhances tissue characterization, differentiating myxoma from thrombus or other primary cardiac neoplasms through perfusion patterns and late gadolinium enhancement.7 In this case, comprehensive multimodality imaging was critical not only for diagnosis but also for defining the anatomical relationship across the septum, thereby facilitating surgical strategy. Complete resection of the tumor and surrounding tissue minimizes recurrence, which occurs in approximately 1% to 5% of sporadic cases, but increases to 15% to 22% in patients with Carney complex.3,8 Operative mortality in experienced centers is low, and the favorable postoperative course observed in this patient reinforces the benefit of timely intervention, even in the absence of symptoms.2,6 Postoperative complications often include supraventricular arrhythmias due to atrial manipulation, with some risk of recurrent interatrial communication in biatrial myxoma cases.2 Outcome and Follow-Up The postoperative course in our patient was notable only for transient sinus bradycardia requiring a temporary pacemaker for 72 hours. She was discharged on day 6. At the 1-year follow-up, she remained asymptomatic; TTE showed no residual mass or shunt and normal biventricular function. Conclusions Biatrial myxoma connected across the fossa ovalis is exceptionally uncommon yet carries dual-chamber embolic risk. Multimodality imaging secures diagnosis and anatomic definition, while prompt en bloc surgical excision ensures definitive cure with excellent prognosis. Clinicians should suspect this entity whenever mobile, opposing atrial masses share a septal stalk to avert complications. Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose. Footnotes The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center. Appendix For a supplemental video, please see the online version of this paper. Appendix Video 1 Two-Dimensional Transesophageal Echocardiography 4-Chamber View Depicting the Myxoma in the Left and Right Atria With Prolapse of Each Mass Into the Respective Ventricle References Associated Data Supplementary Materials Video 1 Two-Dimensional Transesophageal Echocardiography 4-Chamber View Depicting the Myxoma in the Left and Right Atria With Prolapse of Each Mass Into the Respective Ventricle